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Abstract
Epicardial  ablation  has  lately  become  a  necessary  tool  to  approach  some  ventricular 
tachycardias in different types of cardiomyopathy. Its diffusion is now limited to a few high 
volume centers not because of the difficulty of the pericardial puncture but since it requires 
high competence not only in the VT ablation field but also in knowing and recognizing the 
possible complications each of which require a careful treatment.                                    
This article will review the state of the art of epicardial ablation with special attention to the 
procedural aspects and to the possible selection criteria of the patients.
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Introduction
Epicardial ablation, introduced in 1996 for a very selected patient population, has become over 
the years, an intriguing technique for the treatment of ventricular tachycardia(VT) in different 
cardiomyopathies.  Currently  used  only  in  few high  volume centers  with  the  subxyphoidal 
puncture,  the  epicardial  ablation  is  performed  mainly  after  a  previously  failed  endocardial 
approach and only in  few cases  as  a  first  choice.                                       
The very limited experience available for this procedure probably explains why it is included in 
the last Expert Consensus on Catheter Ablation of Ventricular Arrhythmias [1] as a possible 
way of treatment of VT in different settings without, however, including it in the statements of 
the  guidelines.                                          
This article will review the "state of the art" of epicardial ablation with special attention to the 
procedural aspects and to the possible selection criteria of the patients.                           
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Technical  considerations                                          
How to perform pericardial access
The subxyphoidal pericardial  puncture is currently performed using the technique originally 
proposed  by  Sosa  et  al  [2].                                        
 
Starting from the border of the subxyphoidal process, a Tuohy needle is advanced toward the 
left shoulder at  45° angle from the skin's surface and at the same angle from the middle line of 
the sternum.  To a more precise evaluation of the anatomy and of the position of the heart  
inside the thorax, one catheter in right ventricle and one in the coronary sinus may be useful 
references. To this point a continuous check in RAO and LAO view (Figure 1)  with the X-ray 
is recommended during the advancement of the needle tip toward the cardiac silhouette.
Figure  1  A:  direction  of  the  needle  in  RAO view   B:  direction  of  the  needle  in  LAO view.  See  text  for 
explanations
To understand at best the position of the needle, some operators use a small amount of contrast  
media to image "pericardial tenting" like in the transeptal puncture (Figure 2). Once the needle 
is in the pericardial space, conventional Seldinger technique is used to introduce a 9F sheath 
that allows not only the insertion of the mapping catheter in the pericardial space but also,  
through the side port,  the drainage of fluids introduced with the irrigated catheter.  For this 
approach we prefer to use a long sheath (23 cm.) instead of the conventional one of 11 cm, 
because using the latter increases the possibility to lose the access, particularly in patients with 
a large thorax. To reduce this risk it  is strong recommended, before removing the wire, to 
verify the position of the sheath with the injection in the pericardial space of a small amount of 
contrast media (Figure 2).
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Figure 2  a: pericardial tenting during epicardial puncture. B: the presence of the wire that goes from left to right  
is the safest way to be sure that the wire is in the pericardial space and not in a ventricular chamber  c: injection of 
the contrast before remove the wire is important to be sure that the distal part of the sheath is in the pericardial 
space and not outside like in d. The presence of the wire allows the reinserction of another sheath in cases like D 
where  the  sheath  is  outside  the  pericardial  space                                                    
In some cases the selective approach of the anterior wall of the right ventricle may be useful 
instead of the usual inferior-left lateral wall of the heart. This can be obtained using a smaller  
angle than the conventional 45° angle to the skin surface. To overcome this need in the last few 
months we have used a steerable sheath specially designed for the pericardial approach (Agilis 
Epi@ St. Jude Medical) which permits the easy achievement of all areas warranting a stable 
contact  with  the  epicardial  surface.                                         
We usually  remove  the  sheath  at  the  end  of  the  procedure  if  epicardial  ablation  was  not 
performed and if there is no blood in the drainage system. Otherwise, to avoid unintentional 
damage of the myocardial wall, a pigtail is left in place. In this case the sheath is removed, after 
an echo check to exclude the presence of pericardial fluid 24 hours later.                      
It  is  important  to  remember,  before  removing  the  sheath,  the  injection  of  corticosteroids 
(triamcinolone acetonide 2 mg/kg) to prevent post-procedure pericarditis.                                 
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Any  pericardial  procedure  must  be  carefully  planned  and  performed  always  before  the 
endocardial approach and therefore before starting with the anticoagulation therapy.         
There are some cases where the subxypoidal puncture or the epicardial mapping is not possible 
due to the presence of inflammatory pericardial adherence. In this situation we usually call the 
surgeon who carries out a Marfan window which simply permits to reach the epicardial surface 
and the removal of the adherence when present. The Marfan window is performed with a 4-5 
cm  cutaneous incision just below the xyphoid process; adhesions are carefully divided, an 8 
French  sheath  is  advanced  in  the  pericardial  space  and  finally  the  parietal  layer  of  the 
pericardium  is  closed.                                                  
In  infrequent  cases  (concomitant  heart  surgery,  inefficacy  of  RF energy  -  epicardial  fat  -, 
impossibility  to  perform RF ablation  -  adherence,  presence  of coronary arteries  or phrenic 
nerve -, impossibility to perform the pericardial puncture) the ablation can be performed with 
open chest  in the operating  theatre  using the CARTO system and the cryo-energy.  In this 
setting,  due to  the difficulty  to  induce the clinical  arrhythmia  and  for the impossibility  to 
compare the ECG morphology, a sinus rhythm based mapping and ablation procedure will be 
applied.
Complications
Evaluating  complications  occurring  during  an  epicardial  ablation  we  have  to  differentiate 
between  those  which  can  occur  during  the  subxyphoidal  puncture,  during  the  ablation 
procedure  and after  the  procedure.                                                   
Among the possible complications that can occur during the puncture, we have to bear in mind 
that damage of all subdiafragmatic organs can occur. Damage of  the liver, stomach or colon 
may occur  particularly  in  prone subjects.  Patients  with right  heart  decompensation  or  with 
megacolon, for example, have to be carefully evaluated before the procedure if necessary also 
with a CT scan. Two cases of abdominal bleeding due to damage of a diaphragmatic vessel are 
reported in the literature [3]. One [4] of these occurred in our center two years ago and was 
discovered 3 days after the procedure because of the presence of progressive anemia in the 
absence of pericardial effusion and without any other significant abdominal symptoms. In both 
cases abdominal surgery was required to control the bleeding.                                      
Another possible complication occurring during the puncture is  the pleural catheterization with 
guidewire  reported  in  one  study  population  in  1.5% of  cases  that  usually  occurs  without 
pneumothorax  or  complications.                                               
Main cause of epicardial bleeding may be due to damage to the myocardial wall (usually the 
right ventricle) or to a coronary artery occurring during the puncture or during RF ablation. 
This complication is reported in 30% of cases in the study population of Sosa and coll [3] and 
usually doesn't preclude the procedure. In more recent publications [4,5],  a lower incidence is 
reported  (between  3.7  and  4.5).  The  simple  puncture  of  the  right  ventricle  is  not  usually 
followed by pericardial blood effusion. This complication called "dry right ventricle puncture" 
is reported in 4.5% to 17% of cases and will definitely decrease as skill improves. To avoid 
more important damage to the myocardial wall during the puncture it is really important, in 
doubtful cases, to check the position of the tip of the needle with a small amount of contrast 
before inserting the guidewire and in any case to insert it very gently.                                    
A common  minor  complication  is  the  postprocedure  pericarditis  with  different  degrees  of 
severity  that  usually  cause  postprocedure  chest  pain  (21%  of  cases  [4]).  To  reduce  the 
occurrence of this  complication it  is  important  to remove the pericardial  sheath as soon as 
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possible and the routine pericardial infusion of steroids before removing it.                          
Coronary  arteries                                       
Another  important  problem that  we can  encounter  during  epicardial  ablation  is  due  to  the 
presence of the epicardial vessels. Although larger vessels are probably protected by the blood 
flow [6] it was empirically suggested to consider 12 mm as the minimum optimal distance of 
the ablating tip catheter from the coronary vessel. Nevertheless average distance reported in the 
study of Della Bella [4] is 8.6±7.8 mm  and in the last guidelines is strictly suggested to deliver 
RF energy maintaining a minimum distance >  5 mm from the coronary artery [1].             
It is always stronglyrecommended to perform a coronary angiography to clarify the position of 
the tip of the ablating catheter compared to the vessel. For the difficulty to visualize in a 3D 
way an object of which we have only two-dimensional images, the concurrent use of a 3D 
electro-anatomical map may be a useful tool with which we can annotate over the map tags 
displaying the course and position of the coronary artery.                                        
Another helpful possibility is provided by the use of merge capabilities of the mapping system 
that  allows  the  superimposition  over  the  electro-anatomical  map  of  the  anatomical  images 
obtained with a CT (Figure 3). In frequent cases, with the surface rendering tools included in 
the system, a clear visualization of the major coronary arteries can be obtained.
Figure 3. A: Coronary angiography performed with the ablating catheter in a site where, during VT, a diastolic  
potential was registered. The tip of the catheter is close to the LAD artery.  B: Carto bipolar map merged with the 
epicardial anatomy obtained with a CT. Catheter tip (arrow) is shown in the same position of that registered during 
angiography.
In the most important published experiences damage to a coronary artery is reported in one 
case by Sosa [3] and in one by Sacher [5]. No damage was reported in Della Bella's survey [4].  
Although all recommend the use of coronary angiography it is interesting to note that in the last 
paper it was only performed in 43% of cases, with a wide variation among centers (15% - 
87%). Maybe this is due to the fact that in some cases, particularly in the lateral wall of the 
right ventricle or in big true scar areas, there are regions where the likelihood to find major 
coronary  arteries  is  very  low  and  if  the  operators  feel  sure  of  themselves  the  coronary 
angiography  can  be  avoided.                                            
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In  addition,  the  use  of  anatomical  images  obtained  with  CT  scan  and  the  merge  process 
available with the CARTO technology could explain the reduced  recourse to the angiography. 
Phrenic  nerve                                          
The position and the course of the phrenic nerve may in some cases be an important obstacle to 
the delivery of RF energy. While the damage to the right phrenic nerve that usually descends 
along the superior vena cava and along the right atrium is described occurring during ablations 
of atrial  arrhythmias [7,8], the left may be damaged during the ablation of VT. This nerve 
usually runs along the lateral wall of the left ventricle but many different positions have been 
described [9]. Different strategies have been proposed over the years to localize the course of 
the nerve and to avoid damage during RF delivery in site near the nerve. The latter are usually 
described as a  case report  or in small  groups of patients  but none has been systematically 
evaluated in big populations. Even if the course of the phrenic nerve could be identified with 
imaging technique, the only easily feasible way to detect the presence of the nerve is the use of 
high  intensity  pacing  that  must  be  performed  checking  the  presence  of  the  diaphragmatic 
capture also with X-Ray [10]. Care must be taken to perform this test, in case of intubated 
patients, after  antagonization of any muscle relaxants.                                       
Specific  problems                                         
Fat
One of the most important problems in the setting of epicardial ablation is the presence of fat 
that can significantly reduce the efficacy of the RF energy.                                 
Fat,  normally  present  on  the  epicardial  surface,  is  increased  in  patients  with  CAD and  is 
correlated positively with the staging of the cardiomyopathy [11]. Moreover, in patients with 
CAD,  fat  is  thicker  than  in  patients  without  cardiomyopathy  (4  vs  1.5  mm)  [12].        
Although  the  use  of  irrigation  during  RF  application  energy  with  a  low  electrode-tissue 
interface temperature avoids an excessive impedance rise and permits larger and deeper lesions 
than dry RF, fat significantly reduces its effectiveness. Using an in vitro model, Hong et al. 
[13] demonstrated that epicardial fat can significantly limit the efficacy of lesions induced with 
energy that  utilizes  conductive  heating.  D'Avila  et  al.  [14]  evaluated  the  difference  of  the 
lesions obtained with standard and cooled tip RF energy. Lesions created in normal epicardial 
tissue  with  standard  and  cooled-tip  RF  ablation  were  3.7  mm  and  6.7  mm  in  depth, 
respectively.
In areas covered by epicardial fat (3.1±1.2 mm thick), standard RF energy did not generate any 
significant lesions, but cooled-tip RF lesions were 4.1±2 mm in depth. In the presence of a fat 
layer > 3.5 mm, cooled-tip RF was unable to produce epicardial lesions.                            
At  the  moment  the  only way that  we have  to  assess  epicardial  distribution  is  the  use of 
imaging  techniques  like  CT  scan  and  MRI.  Abbara  et  al.[15]  studied  the  epicardial  fat 
distribution  and  thickness  in  59  patients  who  underwent  cardiac  CT  for  coronary  artery 
assessment. Fat was significantly present around the AV groove and over the right ventricle. 
On the contrary fat thickness was small over the lateral and inferior wall of the left ventricle. 
Epicardial fat was also 22% greater in older patients than in young ones.                              
Knowing the epicardial fat distribution is important not only to determine the possibility to 
obtain effective lesions but also because epicardial fat may mimic scar area. Desjardins and 
coll.  [16] in a small  patient  population have recently  found that  a  fat  thickness  ≥ 2.8 mm 
resulted in voltage attenuation and could identify, with good sensitivity and specificity, areas 
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with low bipolar voltages (<1.5 mV). Nevertheless, in an older paper D'Avila [17] found that in 
the presence of fat thickness <5 mm there was no significant difference in the peak-to-peak 
bipolar voltage amplitude, in the bipolar electrogram duration and in the pacing threshold. Fat 
layers > 5 mm made ventricular capture impossible even at 10 mA.  Based on these data and on 
our experience we think that fat is probably able to mimic scar but only when thickness is 
really high as usually happens, in normal patients, along the AV groove.                              
How to consider a patient for an epicardial ablation                                    
Type  of  cardiomyopathy                                             
First  published  experiences  about  epicardial  ablation  [18-23]  include,  in  small  patient 
populations, different types of structural heart diseases. In those days epicardial ablation was 
mainly  performed as  a  rescue  procedure  and almost  always  only  after  a  previously  failed 
ablation. Over the years the experience in epicardial access has been more and more increasing 
and,  particularly  in  high  volume  centers  it  has  become  a  routine  procedure.  The  current 
problem, now, is not only in which type of cardiomyopathy we have to perform the epicardial 
ablation but, above all, when an endo-epicardial ablation must be performed as first choice.  
One cardiomyopathy in which the expression of the pathological processes may have in some 
cases  a  predominant  expression  not  only  adjacent  to  the  valve  annulus,  deep  in  the 
endocardium but also in the epicardial surface is the idiopathic dilated cardiomyopathy. This 
condition already exposed in the past by Perlman et al. [24] has become increasingly evident 
over the years. In one series of IDCM patients using a combined endo-epicardial approach, 
Soejima et al.[22] reported a success rate of  54% during a mean follow-up of almost one year. 
In this study the average epicardial scar area was 37.5 ± 10.4 cm2 (range 22 to 47.3 cm2). In the 
five patients with both epicardial  and endocardial  mapping, the scar area was larger on the 
epicardial surface than on the endocardial surface. In another recent paper published by Cano e 
coll [25] twenty-two patients with IDCM underwent  endo-epicardial bipolar voltage mapping 
and VT ablation. In the 18 patients the mean scar area was greater in the epicardium than in the 
endocardium (55.3 ± 33.5 cm2  vs. 22.9 ± 32.4 cm2, p < 0.01). Epicardial low-voltage areas 
showed 49.7% of  wide  split,  and/or  late  electrograms  usually  not  present  in  the  reference 
patients (2.3%). During follow-up of 18 ± 7 months, no recurrence of VT was identified in 14 
out of 18 patients (78%) with epicardial VT. These results may explain the low success rate of 
IDCM patients ablated only in the endocardium. In a patient population presented by Schmidt 
et  al  [26]  with  previously  failed  endocardial  ablation  for  VT,  15  patients  with  IDCM 
underwent epicardial mapping. In this group of patients epicardial pathological potentials were 
found  in  80%.                                           
Another structural heart disease in which the epicardial evaluation may be capital to increase 
the success rate of the ablation procedure is  the arrhythmogenic right ventricular  dysplasia 
(ARVD). In order to understand the reason why epicardial access must be considered in this 
type  of  cardiomyopathy,  we  have  to  remember  that  this  peculiar  myocardial  disease, 
characterized by replacement of myocytes by fibro-fatty tissue usually involving in the early 
stage the  right  ventricle,  occurs  from the epicardium to the  endocardium [27].  VTs in  the 
setting of ARVD were historically  approached,  in the first published papers [28-37] in the 
endocardium. Although a comparison of the results obtained in these studies is obviously not 
possible because the difference in the ablation strategy, procedural endpoints, AAD therapy 
and follow-up we can observe that the reported acute success is widely spread (50-90%) and 
the  recurrence  rate  increases  significantly  over  the  years.  Wichter  et  al.[33]  in  his  patient 
population reported an acute success in 22 patients (73%). However, during a follow-up period 
of 52 ± 37 months, 18 patients (60%) suffered from VT recurrence or syncope. The event-free 
survival was 63% after 1, 43% after 3, and 32% after 5 years respectively. This trend, also 
present in other papers, can only be in a measure explained with the disease progression of the 
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involvement of the right ventricle and, in rare cases, of the left ventricle. Interestingly enough, 
in none of these experiences the epicardial surface was approached. The need of this approach 
has been clearly initially proved in some papers in which, however, it was always considered 
only as a complementary approach after one or more previous failed endocardial ablations [38-
40]. In one of these papers [38], 13 patients, in which endocardial ablation failed to control 
clinical VTs, underwent endo-epicardial  mapping and ablation procedure.  Regardless of the 
good results obtained in the follow-up (no recurrences in 77% of patients after 18±13 months) 
some important findings that underline the relevance of the epicardial approach in this patient 
population  have  to  be  underlined.  In  all  patients  the  scar  area  was  more  extensive  on  the 
epicardium (95±47 versus 38±32 cm2; P<0.001) and was uniformly marked by multicomponent 
and late potentials. Epicardial VTs were targeted opposite normal endocardium in 10 patients 
(77%) and/or opposite ineffective endocardial ablation sites in 11 patients (85%). Interestingly 
enough the  right  basal  wall  evaluated  with the  electro-anatomical  maps resulted  thicker  in 
ARVD patients  (  > 10 mm) as  compared to  the reference  patients  without  structural  heart 
disease (5-10 mm) and to this end we have to remember that irrigated RF energy delivery in the 
endocardial surface is unable to produce transmural lesions. Another paper that strengthens the 
importance of an endo-epicardial approach in this type of cardiomyopathy has been published 
by  Bai  et  al  [41].  Forty-nine  patients  with  ARVD  divided  into  two  groups  underwent 
endocardial ablation alone (group 1) or endo-epicardial ablation (group 2). After a follow-up of 
at least 3 years, 52.2% of patients in group 1 and 84.6% in group 2 (p<0.029), were free from 
VAs or ICD therapy. Antiarrhythmic therapy was present in 78.3% in group 1 and in only 
30.8% in the endo-epicardial ablation group (P<0.001). Therefore epicardial approach seems to 
be unavoidable for ARVD patients but we have to remember that just in this structural heart  
disease it  is not free of problems. As pointed out by Abbara et  al15 epicardial  fat  resulted 
significantly present not only around the AV groove but also around the right ventricle. It’s 
presence could make it hard to achieve  an effective result with the use of irrigated RF energy.
Curiously enough the first published studies about epicardial ablation involved predominantly 
patients with CAD in which, compared with the previous, the need of this approach is probably 
less important. The reason of this is probably due to the history of VT catheter ablation which 
started just in this  type of patients suffering from tolerated monomophic VT.              
In  the  setting  of  a  necrotic  scar,  the  substrate  for  a  VT is  determined  by the  presence  of 
surviving ventricular muscle fibers included in dense connective tissue. Myocardial fibers on 
the endocardial surface of infarcts or aneurysm may survive because they receive blood directly 
from the ventricular cavity or from the retrograde perfusion through the sinusoidal channels 
[42,43].  The  fibers  entrapped  in  the  fibrotic  tissue,  have  ultrastructural  and  consequent 
electrophysiological abnormalities which may form the basis for a reentry mechanism [44]. 
This  peculiar  anatomical  condition  may  also  develop  in  areas  adjacent  to  the  myocardial 
infarction where the reduced myocardial blood flow may cause subendocardial ischemia with 
focal necrosis and subsequent fibrosis. This condition may explain the success, obtained with 
the endocardial excision [45] of the surgical treatment of VT. Therefore, in this situation, it is 
reasonable to  infer  that  the optimal  treatment  for  VTs is  the endocardial  ablation.         
As proved in an old animal study [46], irreversible myocardial ischemic damage occurs from 
the  subendocardium  toward  the  subepicardium.  This  progression  is  in  function  of  time: 
transmural necrosis was 38 ± 4% after 40 min, 57 ± 7% after 3 hours, 71 ± 7% after 6 hours 
and 85 ± 2% after 24 hours of ischemic injury. The subepicardial myocardium in relation to the 
infarct size has the highest likelihood of no necrosis therefore also in this condition we can 
suppose that  it  can be  substrate  for  VT.                                                
The  recent  changes  in  the  treatment  of  myocardial  infarction  with  the  early  reperfusion 
technique  has  modified  the  main  characteristics  of  the  necrotic  scars  with  more  patchy, 
nontransmural distribution of necrosis [47]. This condition has increased the complexity of the 
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arrhythmic substrate increasing the number of slow conduction areas and VT exit points which 
can be located not only in the subendocardial scar or in the border zone of the myocardial  
infarction but also deep in the myocardial  wall  or in the subepicardial  layers.              
In  two  previous  multicenter  randomized  trials  [48,49]  of  endocardial  VT  ablation  after 
myocardial  infarction,  despite  of  the acute  results  nearly  half  of the whole population  had 
recurrences  at  the  end  of  the  follow-up.                                            
The complexity  of the substrate  and the not always encouraging results  of the endocardial 
ablation  has  motivated  some EP laboratories  to  approach ischemic  patients  with  an  endo-
epicardial procedure, particularly after a previously failed endocardial approach. Considering 
the two most important published series, in the paper of Sacher [5] 16% of the total population 
of  ischemic  patients  was  submitted  to  an endo-epicardial  ablation;  90% of  this  group had 
previously been submitted to an endocardial ablation. This percentage is more reduced in the 
paper of Della Bella [4] where of 85 patients with CAD, 32.9% were submitted to an endo-
epicardial ablation as first choice. Interestingly enough in 12.9% there was only an epicardial 
approach.  In  other  series  epicardial  ablation  was  performed  only  after  failed  endocardial 
ablation. Schmidt et al [50] evaluated the role of epicardial ablation in different structural heart 
diseases after a failed endocardial approach. 11 patients had an ischemic cardiomyopathy and 
five an  inferior  scar.  In  another  single centre  experience  [51]  of  17 patients  with CAD, 7 
underwent an endo-epicardial  ablation (5 with surgical  approach).  All  three patients  with a 
putative epicardial isthmus site had an inferior scar. In another recent paper [52] 280 patients 
with CAD were divided into two groups: patients without previous ablation and patients with 
one or more previously failed endocardial ablations underwent an endocardial ablation in the 
first  case  and  an  endo  or  endo-epicaridal  ablation  in  the  second.  VT recurrence  rate  was 
surprisingly higher in the second group in which septal or inferior scars were more common.    
Based on this data, although someone [53] has supposed that the presence of an inferior scar 
can predict a failure of an endocardial ablation and the need for an epicardial approach, we 
believe that the possibility to have an epicardial scar in ischemic patients, even if infrequent, is 
always possible independently of the previous treatment (early reperfusion or not) and as most 
ischemic VTs can be successfully targeted from the endocardial surface, an epicardial approach 
must  always  be  considered  in  the  presence  of  previously  failed  endocardial  ablations.
ECG  criteria                                            
Several papers have been published in the last few years suggesting different flow-charts to 
recognize  an  epicardial  origin  of  a  VT.                                          
The first significant paper published by Berruezo e coll [54], suggested 4 different criteria with 
which an epicardial origin of a VT could be identified with good sensitivity and specificity. 
After the evaluation of the QRS morphology of endo-epicardial pacing and of 49 VTs in 9 
patients (6 of whom with CAD), a pseudo deltawave ≥ 34 msec, an intrinsecoid deflection time 
≥ 85 msec, an R/S complex duration ≥ 121 msec  have proven to be optimal parameters to 
guide the  recognition  of  an  epicardial  source.                                           
A following paper [55], suggested different region-specific morphologic criteria based on the 
initial vector of the QRS complex. Furthermore Authors found that the criteria proposed by 
Berruezo are in fact useful but sensitivity and specificity are significantly different depending 
on the different LV regions because not only the type of the structural heart disease but also the 
different  regions  of  the  LV  may  significantly  affect  the  initial  conduction  delay  of  the 
epicardial  VT on which these criteria  are  based.                                         
In  non  ischemic  cardiomyopathy  Valles  [56]  published  an  algorithm  for  identifying  an 
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epicardial origin from basal superior and lateral  left ventricle VT. With the absence of a q 
wave in the inferior leads, a pseudo delta wave > 75 ms a maximum deflection index > 0.59 
and the presence of a q wave in lead D1 are indicative of an epicardial origin.              
Recently Martinek e coll [57] evaluated the morphological criteria of 63 endo/epicardial VT in 
patients with CAD. None of the previously proposed criteria for non ischemic patients was 
reliably able  to identify an epicardial  origin of a VT.                                     
Considering ECG criteria we have to keep in mind that in some cases the critical part of the 
reentry circuits may be located in the endocardium but the broad exit is in the epicardium and 
on the contrary in other an endocardial VT may be maintained by an epicardial reentry circuit.
In conclusion we think that ECG criteria are certainly useful to identify an epicardial origin of a 
VT but they have to be used only as a last resource and always after the evaluation of the type 
of  the  cardiomyopathy  and  imaging.                                       
To plan a procedure, general rules that are almost always useful are: consider the presence of: 
-1.  bundle branch block:  RBBB means a  free wall  exit  site  and LBBB a septal  exit  site.  
-2. QRS axis: inferior axis indicates a superior exit and superior axis an inferior exit site.  
- 3. the horizontal plane that can differentiate between basal and apical exit sites.                       
Imaging
The use of imaging technique has progressively increased over the years. By providing detailed 
anatomical  and  metabolic  information  about  normal  and  pathological  myocardium,  it  can 
improve the VT ablation  procedure and the results.  Of the three main imaging modalities, 
contrast-enhanced (CE) CT and delayed-enhanced cardiac magnetic resonance imaging (DE-
MRI) are able to provide very high resolution 3D images of the anatomy of the ventricles and 
of  the  myocardial  scars.  3  Fluorodeoxyglucose  (FDG)  PET  can  add  important  metabolic 
information.
The first use of imaging integration (registration with the heart of 3D images obtained with CT 
or  MRI)  was  first  reported  in  animals  in  2003 [58].  Ever  since,  with  the  development  of 
CartoMerge system by Biosense Webster and the NavX Fusion by St. Jude Medical, imaging 
integration  has  been  increasingly  used  especially  in  atrial  fibrillation  ablation  where  its 
capability to show detailed images of the left atrial anatomy has permitted more precise and 
effective  procedures.  For  the  same  purpose  imaging  integration  can  be  used  to  define 
anatomical structure of the ventricles and above all of the epicardial surface where it can show 
the  course  of  the  main  epicardial  arteries.  However  the  most  important  use  of  imaging 
technique in VT ablation is connected to the capability to identify and display functional and 
pathological characteristics of the myocardial tissue, knowledge of which is crucial in these 
type of procedures. Reentry or focal VT in the setting of structural heart disease are always 
supported by myocardial scars. To this end the use of imaging techniques able to identify and 
localize in a 3D way the presence of these scars may help to plan the procedure and to reduce 
the  procedural  time.                                               
Dickfeld et al. were the first to report this use in 2008 [59]. In this study performed in fourteen 
patients who underwent a PET/CT before VT ablation, Authors proved its capability to asses 
the  left  ventricle  scars  and  border  zones  and  the  possibility  to  obtain  supplementary  scar 
characterization,  with  the  integration  of  the  3D  scars  in  the  electro-anatomical  maps.
Contrast-enhanced cardiac magnetic resonance (CE-CMR) may be currently considered as the 
gold standard for the evaluation of the myocardial perfusion, of the myocardial viability and of 
the ventricular function. Several papers [60-63] have in the past highlighted its role in ischemic 
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patients with the analysis of the infarct size and the periferal zone to strongly predict not only 
the inducibility of ventricular arrhythmias but also the cardiovascular mortality. Next to this 
applications  MRI  has  been  increasingly  used  to  guide  ablation  procedures.  All  published 
papers,  which  considered  a  small  number  of  CAD  patients,  have  confirmed  that  scar 
characterization obtained with high resolution MRI looks similar to that obtained with electro-
anatomical mapping. Unlike the bipolar or unipolar voltage maps, MRI provides additional 
information about the scar geometry providing the possibility to predict  the location of VT 
circuits.  In  all  cases  all  this  information  can be integrated  and registered  with the  electro-
anatomical map to guide the procedure. Although images have been obtained with different 
algorithm and different protocol have been used for the post-processing, a common finding is 
that there is a constant mismatch between scar areas identified with EAM and those identified 
with CE-MRI. Codreanu et al. [64] found a clear mismatch of 20% in 33% of infarct areas: in 3 
cases scars identified with EAM were not confirmed on MRI, in 1 EAM underestimates the 
scar revealed with MRI. Desjardins [65] using a cutoff value of 1.5 mV to define scar tissue 
found a mismatch of 29%. The observed variance between EAM and scars at MRI was justified 
with  the  poor  contact  of  the  mapping  catheter  with  the  endocardial  surface,  with  the  low 
density  of  the  electroanatomical  map  or  with  the  low  spatial  resolution  of  the  CE-MRI 
technique applied.  A reduction of this discrepancy has been obtained in a recent published 
paper  [66]  using a  a  high-density  EAM and a high  spatial  resolution  CE-CMR technique. 
Applying a cutoff value of 60% of the maximum pixel signal intensity to discriminate between 
core and border zone of the scar a very good match has been obtained between core identified 
with EAM and those with CE-MRI. Despite this improvement core scars identified with EAM 
remain slightly smaller. This may be explained, according to the Authors, by the effect of the 
far-field signals generated by the surrounding healthy tissue that could reduce the area where 
low  voltages  are  registered.                                           
The  recent  technological  improvement  of  contrast  enhanced  CT  has  permitted  detailed 
evaluation of the functional state and viability of ischemic and non-ischemic myocardium. Due 
to his high spatial ( <1mm) and temporal resolution some EP laboratories have begun to use 
this  technology  to  improve  VT  ablation.  A  good  correlation  between  areas  of  abnormal 
myocardium with low voltages (<1.5 mV) and CE-CT hypoperfusion was found . Interestingly 
CE-CT was also able to characterize the transmural extent and the intramyocardial location of 
the scar. Given this possibility, the better definition of the anatomical details and feasibility to 
perform this exam also in patients with an ICD it is possible that in the future CT-CT will be 
increasingly used in the setting of VT ablation (Figure 4).
In conclusion we think that, regardless of the type of technology used and the capability to best 
discriminate core scar from the border zone, the routine use of imaging before a VT ablation is 
mandatory to clearly identify the arrangement of the scars in order to plan the mapping and the 
ablation  strategy.                                           
Conclusions
The epicardial ablation is an essential approach that must be available in an EP laboratory but 
the  complexity  of  all  the  problems connected  limits  it  extensive  use  only  in  high  volume 
Centers provided of the necessary skillnes and competences. Only in this case this procedure 
can be considered applicable and may report a low rate of complications.                               
In  the  decision-making  strategy  the  most  important  rule  is  carried  out  by  the  type  of  the 
cardiomyopathy. Patients with IDCM or ARVD should probably be submitted directly to an 
endo-epicardial approach while on the contrary ischemic patients should be submitted to an 
epicardial  ablation  only  after  a  previous  failed  endocardial  ablation.  In  any  case,  a 
preprocedural evaluation with an imaging technique ( CT or MRI) is mandatory and must be 
considered as integral part of the decision-making process.                                   
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Informations  obtained  from the  surface  ECG,  when available,  are  certainly  useful  but  not 
pivotal.
Figure  4.  A  case  presenting  good  correlation  between  pathological  area  identified  by  cardiac  CT  and  by 
electroanatomical  map.  A.  Cardiac  CT  showed  small  scar  in  posterolateral  wall  in  left  ventricle  B.  Late 
enhancement of cardiac muscle was not seen in subendocardial region but seen in mesocardial and subepicardial  
portion. C and D. Electroanatomical mapping of epicardial space (left panel) and endocardial (right panel) of LV. 
The scar identified by CT was correspond to the border of low-voltage area in epicardial bipolar voltage map (C) 
and area with late potentials in local activation map (D) whereas there was no pathological region in endocardial  
map. (Radiofrequency energy was delivered epicardially. After abolishing all late potentials, VT was no longer 
inducible.)    
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Further research for development of dedicated energy delivery systems (to permit a selective 
and firmer contact with the epicardial layers and a reduction of possible collateral damage) and 
of  new  energy  sources  able  to  overcome  the  insulating  properties  of  epicardial  fat  are 
desiderable.
Addendum
In the last 80 epicardial procedures we have routinely used the pressure monitoring obtained 
connecting  a  pressure  line  to  the  Tuohy  needle.  With  this  technique  the  needle  must  be 
advanced toward the cardiac silhouette with a slow and continuous movement. This induces a 
progressive  increase  of  the  registered  pressure.  Before  entering  the  pericardial  space  a 
perception of the heart beat is always present and when the needle gets into the pericardial 
space (before that you frequently hear and feel a "click") a sudden drop of the pressure is clear 
on the pressure curve (Figure 5a). This drop is a distinctive sign that the tip of the needle is 
inside the pericardial space and is due to the negative pressure usually present in the pericardial 
space.
Figure  5. Use  of  the  pressure  monitoring  during  epicardial  ablation  is  shown.  A:  Common pattern:  initial  
progressive increase of the pressure during the movement of the needle toward the cardiac silhouette is followed  
by a sudden drop (arrow) when the tip of the needle get into the pericardial space. B: Unusual pattern: in some 
cases the increasing of the pressure is lower and also low is the drop of the pressure (arrow) when the needle reach  
the pericardial space.  The contact of the needle tip with the myocardial wall usually induce VEB or, as in this  
case, VT. C: In some cases, particularly in the presence of soft adherence a drop of the pressure is not clearly  
visible and after the "click" the pressure of the right ventricle appears suddently (black arrow), suggesting that the  
neddle is in the right ventricle.  In these cases,  slight retraction of the neddle allows, when the right ventricle 
pressure  curve  disappears  (broken  arrow),  the  inserction  of  the  wire  in  the  pericardial  space.
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Sometimes the magnitude of the pressure drop is reduced (Figure 5b) (particularly in a non-
empty pericardial space or  in case of adherence) or you can feel two or three "clicks" with 
sudden change of the pressure,  because you have to go across multiple  layers  (diaphragm, 
fibrous pericardium) before you reach to the pericardial space. In any case after a click and a 
pressure drop we check if the wire can procede in the pericardial space.                          
In some cases, probably due to very soft adherence, the "click" is immediately followed by the 
appearance of a pressure curve typical of the right ventricle (Figure 5c). The recognition of this 
condition prevents the insertion of the guide that in cases where the tip of the needle is still 
intramural  could  cause  additional  damage  of  the  myocardial  wall  making  the  epicardial 
bleeding  difficult  to  control  in  a  non-surgical  way.  Moreover  in  these  cases  a  very  slow 
retraction of the needle until the RV pressure curve disappears allows in the vast majority of 
cases  the  advancement  of  the  wire  in  the  pericardial  space.  In  this  situation  we  start 
immediately with the epicardial mapping and anticoagulation for the endocardial mapping is 
started after half an hour. Bleeding in this condition usually stops in a few minutes and doesn't  
exceed  50  ml.                                                     
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